益气复脉注射液通过xCT/GPX4轴抑制铁死亡改善脓毒症诱导的心肌病
该研究在大鼠脓毒症诱导的心肌病(SIC)模型及LPS诱导的心肌细胞死亡模型中,观察益气复脉注射液(YQFM)对心肌铁死亡及xCT/GPX4轴的影响。结果显示,YQFM可减轻脓毒症模型大鼠心肌损伤;SIC大鼠经YQFM治疗后铁浓度及脂质过氧化相关因子(ROS、MDA、4-HNE)水平显著降低,xCT/GPX4轴表达上调;体外实验中YQFM同样减轻铁过载和脂质过氧化并激活xCT/GPX4轴,而GPX4抑制剂可 abolir 上述效应。研究提示YQFM可能通过增强xCT/GPX4轴、减少铁死亡来发挥心肌保护作用。
要点
- 在大鼠SIC模型中,YQFM能有效减轻心肌损伤。
- SIC大鼠经YQFM治疗后,铁浓度及ROS、MDA、4-HNE水平显著降低,xCT/GPX4轴表达上调。
- LPS诱导心肌细胞死亡模型中,YQFM减轻铁过载和脂质过氧化并激活xCT/GPX4轴。
- GPX4抑制剂可 abolir YQFM上述改善铁死亡的作用。
适用人群与场景
- 脓毒症诱导的心肌病(SIC)大鼠模型及LPS诱导的心肌细胞死亡模型。
研究设计与关键结果
- 研究类型:动物实验(大鼠SIC模型)与体外细胞实验(LPS诱导心肌细胞死亡模型)。
- YQFM可减轻脓毒症模型大鼠的心肌损伤。
- SIC大鼠经YQFM治疗后,铁浓度及脂质过氧化相关因子ROS、MDA、4-HNE水平显著降低,xCT/GPX4轴表达上调。
- 体外实验显示YQFM减轻铁过载和脂质过氧化,并激活xCT/GPX4轴。
- GPX4抑制剂可 abolir YQFM上述改善铁死亡的作用。
证据类型、等级与局限
- 证据类型:动物实验与体外细胞实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis-induced cardiomyopathy ( SIC ) is a distinct form of myocardial injury that disrupts tissue perfusion and stands as the significant cause of mortality among sepsis patients. Currently, effective preventive or treatment strategies for SIC are lacking. YiQiFuMai injection (YQFM), composed of Panax ginseng C.A. Mey., Ophiopogon japonicus (Thunb.) Ker Gawl., and Schisandra chinensis (Turcz.) Baill., is widely used in China to treat cardiovascular diseases, such as coronary heart disease, heart failure, and SIC . Research has shown that YQFM can improve cardiac function and alleviate heart failure through multiple pathways. Nevertheless, the mechanisms through which YQFM exerts its effects on SIC remain to be fully elucidated. In this study, we firstly investigated the therapeutic effects of YQFM on a SIC rat model and explored its effects on myocardial ferroptosis in vivo. Then, LPS-induced myocardial cell death model was used to evaluate the effects of YQFM on ferroptosis and xCT/GPX4 axis in vitro . Furthermore, using GPX4 inhibitors, we aimed to verify whether YQFM improved cardiomyocyte ferroptosis through the xCT/GPX4 axis. The results showed that YQFM was effective in alleviating myocardial injury in septic model rats. Besides, the concentrations of iron and the levels of lipid peroxidation-related factors (ROS, MDA, and 4-HNE) were significantly decreased and the expression of xCT/GPX4 axis was upregulated in SIC rats after YQFM treatment. In vitro studies also showed that YQFM alleviated iron overload and lipid peroxidation and activated xCT/GPX4 axis in LPS-induced myocardial cell death model. Moreover, GPX4 inhibitor could abolish the effects above. In summary, the study highlights the regulatory effect of YQFM in mitigating myocardial injury. It probably achieves this ameliorative effect by enhancing xCT/GPX4 axis and further reducing ferroptosis.
参考来源
- Guo L, Li P, Wang Y, et al. YIQIFUMAI INJECTION AMELIORATED SEPSIS-INDUCED CARDIOMYOPATHY BY INHIBITION OF FERROPTOSIS VIA XCT/GPX4 AXIS. Shock. 2023. PMID: 37983962. doi:10.1097/SHK.0000000000002257
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。